Sort
25,944 grants matching “neurodegeneration”
Neural Stem Cell Aging and Neurodegeneration
$541,817Danica Chen · University Of California Berkeley · R01 · FY2024 · AG
The Clathrin Coated Vesicle Cycle
$541,714Sandra L. Schmid · Scripps Research Institute, The · R01 · FY2011 · MH
Single Molecule Approach to Neurodegeneration in Alzheimer's Disease
$541,682Ari Gafni · University Of Michigan At Ann Arbor · R01 · FY2010 · AG
Gene Therapy And Neurodegeneration
$541,554Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2011 · DA
Gene Delivery and Addiction
$541,554Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2011 · DA
Metabolic regulation of KLHL proteins through O-glycosylation
$541,390Jen-Tsan Ashley Chi · Duke University · R01 · FY2019 · NS
Predicting neurodegeneration in living patients by IR imaging of skin fibroblasts
$541,295Aris A Polyzos · University Of Calif-Lawrenc Berkeley Lab · R21 · FY2022 · AG
Super-Resolution Microscopy of Small Quantum Dots to Elucidate the Mechanisms of Alzheimer's Disease
$541,141Paul R Selvin · University Of Illinois At Urbana-Champaign · R01 · FY2016 · NS
A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down Syndrome
$540,902Peng Jiang · Rutgers, The State Univ Of N.J. · R01 · FY2024 · AG
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity (EXEC-study)
$540,816Ulf G Bronas · Columbia University Health Sciences · R01 · FY2024 · AG
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
$540,813Nicholas Francis Fitz · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease
$540,683Theodore R Holman · University Of California Santa Cruz · R01 · FY2021 · AG
TRACKING NEURODEGENERATION IN EARLY WOLFRAM SYNDROME
$540,658Tamara G Hershey · Washington University · R01 · FY2017 · HD
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
$540,619Robert Sidney Rosenson · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG
Neurotoxicity of Reactive Astrocyte-secreted Lipids in Neurodegenerative Disease
$540,463Shane Liddelow · New York University School Of Medicine · R01 · FY2023 · EY
Developing new therapeutic strategies for brain metastasis
$540,115Eva Hernando · New York University School Of Medicine · R01 · FY2023 · CA
A Multidisciplinary Analysis of Gelsolin Amyloid Disease
$540,095Scripps Research Institute · R01 · FY2004 · AG
APOE effects on glial lipid metabolism and 25-hydroxycholesterol: Effects on aging and AD-related pathology
$540,068David M Holtzman · Mayo Clinic Jacksonville · U19 · FY2022 · AG
Replication mechanism of human prions
$540,017Jiri G. Safar · Case Western Reserve University · R01 · FY2012 · NS
Gene Expression in Long-term Memory
$540,016Cristina M Alberini · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · MH
Imaging of glutamatergic system changes in Alzheimer's disease in vivo
$539,879Ravinder Reddy · University Of Pennsylvania · R01 · FY2021 · AG
Toxicodietary and genetic determinants of susceptibility to neurodegeneration
$539,877Daniel Desire Tshala-Katumbay · Oregon Health & Science University · R01 · FY2018 · ES
Proteome-wide analysis of AD-associated SNPs
$539,798Heng Zhu · Johns Hopkins University · R01 · FY2022 · AG
Lysosomal function of progranulin and neurodegeneration
$539,764Fenghua Hu · Cornell University · R01 · FY2022 · NS
Cell Death Pathways in Glaucomatous Neurodegeneration
$539,665Richard T Libby · University Of Rochester · R01 · FY2020 · EY